Laboratorio Reig Jofre (FRA:FEQ1) Cyclically Adjusted PB Ratio: (As of Aug. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:FEQ1 Laboratorio Reig Jofre SA FRA:FEQ1
82 GF Score
Price €2.64
GF Value €2.67
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Laboratorio Reig Jofre Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Laboratorio Reig Jofre  (FRA:FEQ1) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Laboratorio Reig Jofre Cyclically Adjusted PB Ratio Related Terms


Laboratorio Reig Jofre Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Laboratorio Reig Jofre's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Laboratorio Reig Jofre Cyclically Adjusted PB Ratio Chart

Laboratorio Reig Jofre Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.00 0.69 0.77 0.92 0.92

Laboratorio Reig Jofre Quarterly Data
Jun21 Sep21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.09 1.02 0.92 0.87 0.00

FRA:FEQ1 vs ZTS, UTHR, VTRS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Laboratorio Reig Jofre's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laboratorio Reig Jofre Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laboratorio Reig Jofre's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Laboratorio Reig Jofre's Cyclically Adjusted PB Ratio falls into.


FRA:FEQ1
82GF Score
Laboratorio Reig Jofre SA FRA:FEQ1
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Laboratorio Reig Jofre Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Laboratorio Reig Jofre's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Laboratorio Reig Jofre's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=2.694/131.3300*131.3300
=2.694

Current CPI (Jun. 2026) = 131.3300.

Laboratorio Reig Jofre Quarterly Data

Book Value per Share CPI Adj_Book
201606 2.046 100.333 2.678
201609 2.065 99.737 2.719
201612 2.120 101.842 2.734
201703 2.156 100.896 2.806
201706 2.163 101.848 2.789
201709 2.118 101.524 2.740
201712 2.218 102.975 2.829
201803 2.249 102.122 2.892
201806 2.254 104.165 2.842
201809 2.249 103.818 2.845
201812 2.313 104.193 2.915
201903 2.351 103.488 2.984
201906 2.330 104.612 2.925
201909 2.318 103.905 2.930
201912 2.355 105.015 2.945
202003 2.387 103.469 3.030
202006 2.401 104.254 3.025
202009 2.420 103.521 3.070
202012 2.420 104.456 3.043
202103 2.470 104.857 3.094
202106 2.468 107.102 3.026
202109 2.463 107.669 3.004
202112 2.458 111.298 2.900
202206 2.492 118.044 2.772
202209 2.463 117.221 2.759
202212 2.508 117.650 2.800
202303 0.000 118.948 0.000
202306 2.574 120.278 2.811
202309 2.608 121.343 2.823
202312 2.593 121.300 2.807
202403 2.628 122.762 2.811
202406 2.618 124.409 2.764
202409 2.650 123.121 2.827
202412 2.673 124.753 2.814
202503 2.729 125.531 2.855
202506 2.659 127.251 2.744
202509 2.666 126.840 2.760
202512 2.679 128.400 2.740
202603 2.718 129.860 2.749
202606 2.694 131.330 2.694

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Laboratorio Reig Jofre (FRA:FEQ1) Overvalued in 2026?

Based on GuruFocus' analysis, Laboratorio Reig Jofre stock appears to be undervalued. The current stock price of €2.64 is trading 1.1% below its estimated GF Value™ of €2.67. GuruFocus considers Laboratorio Reig Jofre to be Fairly Valued.

Key valuation signals for FRA:FEQ1:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €2.67 vs. price of €2.64 (1.1% below fair value)
  • GF Score™: 82/100 with 7 warning signs

No single metric tells the full story. See the FRA:FEQ1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Laboratorio Reig Jofre Business Description

Other Exchanges 0RB1:UKRJF:Spain
Address Avenida de les Flors, Sant Joan Despi, Barcelona, ESP, 08970
Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.
82GF Score

Get the complete analysis for FRA:FEQ1

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.64
Price
€2.67
GF Value